Company: PFSA
Filing Date: 2025-07-18
Form Type: 8-K
Source: 0001213900-25-065686
Chunk: 36

Company: Profusa, Inc.
Filing Date: 2025-07-18
Form: 8-K
Chunk 36
---
 infrastructure and enhancing existing products and
developing new ones. Furthermore, we aim to continue discussions with potential partners in Asia.

We expect to incur additional
expenses due to operating as a public company, including expenses related to compliance with the rules and regulations of the U.S. Securities
and Exchange Commission (the “SEC”), and those of the Nasdaq Stock Market LLC (“Nasdaq”), additional insurance
expenses, investor relations activities and other administrative, professional and consulting services. As a result of these and other
factors, we expect that we will require additional financing to fund our operations and planned growth. We may also seek additional financing
of any kind. We may seek to raise any additional capital through public or private equity offerings or debt financings, additional credit
or loan facilities or a combination of one or more of these funding sources. In the scenario that we are unable to acquire sufficient
financing or financing on terms satisfactory to our management or Board of Directors, our ability to continue to pursue our business objectives
and to respond to business opportunities, challenges or unforeseen circumstances could be significantly limited, and our business, financial
condition and results of operations could be materially adversely affected.

Business Combination

On November 7, 2022, the Company
entered into the Merger Agreement with NorthView, and on July 11, 2025, the Business Combination closed. In accordance with the terms
and subject to the conditions of the Merger Agreement, at Closing, each share of issued and outstanding Profusa Common Stock was converted
into a number of shares of New Profusa Common Stock, based on the Exchange Ratio that reflects an equity valuation of Profusa of $155,000,000
(as adjusted for the Incentive Equity Value, the Private Placement Value and the Aggregate Company Incentive Amount), divided by an assumed
value of New Profusa Common Stock of $10.00 per share. As of immediately following the Closing, there were 32,788,877 shares of Profusa
Common Stock outstanding, no shares of Profusa preferred stock outstanding, and 17,404,250 Profusa warrants outstanding.

<div align='center'>9</div>

The Business Combination
was accounted for as a reverse capitalization in accordance with GAAP. Profusa was deemed the accounting predecessor of the combined business,
and New Profusa is the successor SEC registrant, meaning that Profusa’s financial statements for previous periods will be disclosed
in the registrant’s future periodic reports filed with the SEC.